Immune Thrombocytopenia (ITP)
3 competing products in clinical development for Immune Thrombocytopenia (ITP).
Pipeline by Phase
Phase 1/22
Phase 21
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pirtobrutinib + Placebo | Eli Lilly | Phase 1/2 | Recruiting | 39 |
| Romiplostim | Kyowa Kirin | Phase 1/2 | Completed | 32 |
| Placebo + Lusutrombopag | Shionogi | Phase 2 | Terminated | 27 |